Earnings Preview: Becton, Dickinson and Co.

Becton, Dickinson and Co. (BDX) is expected to report Q3 earnings before market open Thursday, July 23, with a conference call scheduled for 10:00 am ET.

Guidance

Analysts are expecting a profit of $1.10 on revenue of $1.79B. The consensus range for EPS is $1.07 to $1.12, with a revenue range of $1.77B to $1.81B, according to First Call. For Q2, the company reported EPS $1.09 vs. consensus of $1.04 and revenue of $1.75B vs. consensus of $1.73B.

Analyst Views

Positive drivers for this quarter's earnings include the TriPath acquisition and strength in the diagnostics business. Possible negative influences for this earnings period include a slower life sciences division. Back in late May, Lazard noted that the flow cytometry market is healthy and Becton, Dickinson's business appears sustainable. The firm rated the shares a Buy.

Comments

[BullishBankers]

For an earnings recap check out www.bullishbankers.com.../

[longtermstocks]

I am a big buyer here!